Research in NSW

Sydney - First for Clinical Trials

The NSW Clinical Trials Business Development Centre (ClinicalTrialsNSW) is the first point of contact for sponsors and researchers wishing to find out more about what Sydney and regional NSW, Australia can offer for clinical development.

With its prime location in the Asia Pacific region NSW’s competitive advantages include:

• History of nearly 20 years experience with ICH-GCP guidelines
• Strong research community with many world renowned researchers working in NSW
• Single ethical review for multi-centre clinical trials across the state of NSW
• The regulatory clinical trial notification (CTN) scheme allows for one of the fastest regulatory processing times globally requiring less than 10 days
• The Australian regulatory authority the Therapeutic Goods Administration (TGA) has an FDA- (Food and Drug Administration) and EMEA- (European Agency for the Evaluation of Medicinal Products) compliant regulatory regime
• A strong focus on intellectual property protection.
• A stable business and political environment.

Why Sydney and regional NSW?

• The geographical location of New South Wales in relation to Asia positions NSW as an optimal location for leading clinical trials in Australia and Asia.
• Around 30% of Sydney’s residents are overseas-born, satisfying demographic needs of any clinical trial.
  
• NSW is Australia’s most populous state.
• NSW research institutes are top performers in meeting recruitment timelines and targets.
  
• Our researchers have forged a worldwide reputation for consistent high quality clinical trial research.